BRIEF-Ionis Pharmaceuticals Q3 Revenue USD 157 Million Vs. IBES Estimate USD 131.3 Million

Reuters
Oct 29, 2025
BRIEF-Ionis Pharmaceuticals Q3 Revenue USD 157 Million Vs. IBES Estimate USD 131.3 Million

Oct 29 (Reuters) - Ionis Pharmaceuticals Q3 operating income USD -160 million.

  • Q3 adjusted operating expenses USD 286 million
  • Q3 net income USD -129 million
  • Q3 operating expenses USD 317 million
  • Q3 adjusted operating income USD -129 million vs. IBES estimate USD -196 million

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10